NPPA allows 50% price hike for ibuprofen, ranitidine, carbamazepine

India’s pharmaceutical pricing regulator has allowed a one-time price hike of 50% for ibuprofen, ranitidine and carbamazepine, Business Standard reported.

After the latest increase, the price of carbamazepine, a drug used to treat epilepsy, would range from Rs 1 to Rs 4.61 per tablet. The new price of ranitidine, an antacid, would be in the range of Rs 1 to Rs 2.43 per tablet or per ml of liquid, while the price of ibuprofen, an analgesic, would be 59 paise to Rs 1.04 per tablet.

The National Pharmaceutical Pricing Authority (NPPA) allowed the price hike during its meeting held on June 28.